Most pharma franchises ignore respiratory. Here’s why respiratory-focused PCD is the high-margin, low-competition segment smart distributors are eyeing now.
Why Respiratory PCD Pharma Franchise Is India’s Most Underserved — and Most Profitable — Business Opportunity in 2025